Literature DB >> 9101092

Cyclooxygenase-2 induction and transforming growth factor beta growth inhibition in rat intestinal epithelial cells.

H Sheng1, J Shao, E B Hooton, M Tsujii, R N DuBois, R D Beauchamp.   

Abstract

Rat intestinal epithelial cells (RIE-1) permanently transfected with the prostaglandin endoperoxide synthase 2 (also referred to as cyclooxygenase-2; COX-2) gene exhibit decreased cyclin D1 levels, decreased cdk4-associated kinase activity, and delayed G1 cell cycle progression, which represents a phenotype similar to that which follows transforming growth factor beta (TGF-beta) treatment. In the current study, we have found that addition of TGF-beta 1 to the parental RIE-1 cells (designated RIE-P) caused a rapid induction of COX-2 mRNA and protein. COX-2 protein levels progressively increased and reached peak levels 6 h after TGF-beta 1 addition. Cyclin D1 was decreased by 74% at 6 h and was undetectable 24 h after addition of TGF-beta 1. In RIE cells transfected with the COX-2 antisense expression vector (RIE-AS cells), TGF-beta 1 induction of COX-2 protein was reduced greater than 90%. Addition of TGF-beta 1 did not reduce the abundant cyclin D1 protein expression in the RIE-AS cells, unlike the effect in RIE-P cells. TGF-beta 1 treatment reduced peak [3H]thymidine incorporation by 60% and delayed G1/S-phase transition by at least 4 h in the RIE-P cells. In contrast, S-phase entry occurred at 16 h in RIE-AS cells and was not altered by TGF-beta 1 treatment. Restoration of cyclin D1 expression by transfection of the cyclin D1 cDNA under transcriptional control of the cytomegalovirus promoter/enhancer in the COX-2-overexpressing (RIE-S) cells decreased the time required for S-phase entry by at least 4 h and increased the peak level of [3H]thymidine incorporation. Taken together, the results demonstrate that TGF-beta 1 strongly induces COX-2 at both the mRNA and protein levels and suggest that this induction of COX-2 is involved in the down-regulation of cyclin D1 and inhibition of cell growth caused by TGF-beta 1 in rat intestinal epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9101092

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  16 in total

1.  Synergistic induction of cyclooxygenase-2 by transforming growth factor-beta1 and epidermal growth factor inhibits apoptosis in epithelial cells.

Authors:  D Saha; P K Datta; H Sheng; J D Morrow; M Wada; H L Moses; R D Beauchamp
Journal:  Neoplasia       Date:  1999-12       Impact factor: 5.715

2.  Dietary fiber enhances a tumor suppressor signaling pathway in the gut.

Authors:  Khoa A Nguyen; Yanna Cao; Justin R Chen; Courtney M Townsend; Tien C Ko
Journal:  Ann Surg       Date:  2006-05       Impact factor: 12.969

3.  Cyclooxygenase-2 deficiency leads to intestinal barrier dysfunction and increased mortality during polymicrobial sepsis.

Authors:  Laura E Fredenburgh; Margarita M Suárez Velandia; Jun Ma; Torsten Olszak; Manuela Cernadas; Joshua A Englert; Su Wol Chung; Xiaoli Liu; Cynthia Begay; Robert F Padera; Richard S Blumberg; Stephen R Walsh; Rebecca M Baron; Mark A Perrella
Journal:  J Immunol       Date:  2011-10-03       Impact factor: 5.422

4.  Differential regulation of cyclooxygenase-2 in nontransformed and ras-transformed intestinal epithelial cells.

Authors:  Jianguo Du; Bo Jiang; John Barnard
Journal:  Neoplasia       Date:  2005-08       Impact factor: 5.715

5.  Specific NF-kappaB blockade selectively inhibits tumour necrosis factor-alpha-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells.

Authors:  C Jobin; O Morteau; D S Han; R Balfour Sartor
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

6.  Induction of TGF-beta 1, not regulatory T cells, impairs antiviral immunity in the lung following bone marrow transplant.

Authors:  Stephanie M Coomes; Carol A Wilke; Thomas A Moore; Bethany B Moore
Journal:  J Immunol       Date:  2010-03-26       Impact factor: 5.422

7.  Non-steroidal anti-inflammatory drugs with activity against either cyclooxygenase 1 or cyclooxygenase 2 inhibit colorectal cancer in a DMH rodent model by inducing apoptosis and inhibiting cell proliferation.

Authors:  W A Brown; S A Skinner; C Malcontenti-Wilson; D Vogiagis; P E O'Brien
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

8.  Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells.

Authors:  H Sheng; J Shao; C M Townsend; B M Evers
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

9.  Transforming growth factor β regulates P-body formation through induction of the mRNA decay factor tristetraprolin.

Authors:  Fernando F Blanco; Sandhya Sanduja; Natasha G Deane; Perry J Blackshear; Dan A Dixon
Journal:  Mol Cell Biol       Date:  2013-11-04       Impact factor: 4.272

Review 10.  Cyclooxygenase-2 and its role in colorectal cancer development.

Authors:  Dominique Wendum; Joëlle Masliah; Germain Trugnan; Jean-François Fléjou
Journal:  Virchows Arch       Date:  2004-09-01       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.